Covid-19 News: India’s new COVID weapon: Antibody cocktail explained
The first covid patient in India was treated with the ‘Antibody Cocktail’ in Haryana.
He was successfully treated and was discharged recently from the hospital.
Mohabbat Singh, 82, treated at Medanta Hospital in Gurgaon with a combination of Casirivimab and Imdevimab drugs.
Former US President Donald Trump was also treated with the same combination of antibody cocktail.
Cipla and Roche India have come together manufacturing the drugs to treat persons with mild to moderate coronavirus symptoms.
A single dose treatment costs around 59,000 rupees. A multi-dose pack healing two individuals costs around 1.19 lakh rupees.
Covid-19 News: Moderna claims their Covid-19 vaccine is effective in children aged 12 to 17
